Mode
Text Size
Log in / Sign up

Neurology

1257 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Structured exercise training improves motor performance and modulates TMS neurophysiological markers in healthy adults
Neurology Meta-analysis
Structured exercise training improves motor performance and modulates TMS neurophysiological markers in healthy adults Structured Exercise Training Improves Motor Performance and Brain Markers
This meta-analysis evaluated the effects of structured exercise training on motor performance and TMS-derived neurophysiological markers in …
New data shows that structured exercise programs can improve motor performance and certain brain markers in healthy adults.
FDA Approves Belbuca (buprenorphine) Buccal Film for Severe Persistent Pain
Neurology FDA Approval
FDA Approves Belbuca (buprenorphine) Buccal Film for Severe Persistent Pain FDA approves Belbuca film for severe pain that needs daily opioid treatment.
FDA approved Belbuca (buprenorphine) buccal film for management of severe and persistent pain requiring an opioid analgesic when alternative…
The FDA approved Belbuca (buprenorphine) buccal film for severe, persistent pain that requires daily, around-the-clock opioid treatment and …
AhR signaling exhibits dual neurotoxic or neuroprotective effects depending on specific ligand types
Neurology Sys. Review
AhR signaling exhibits dual neurotoxic or neuroprotective effects depending on specific ligand types Gut Health and AhR Signaling Linked to Alzheimer's and Parkinson's
This systematic review examines the role of Aryl hydrocarbon receptor (AhR) signaling in Alzheimer's and Parkinson's disease. The authors co…
New research highlights how different gut-related signals can either harm or protect the brain in conditions like Alzheimer's and Parkinson'…
DPP-4 inhibitors may reduce drug-resistant epilepsy risk via the gut microbiota and GLP-1 axis
Neurology Sys. Review
DPP-4 inhibitors may reduce drug-resistant epilepsy risk via the gut microbiota and GLP-1 axis DPP-4 Inhibitors May Offer New Hope for Drug-Resistant Epilepsy
This systematic review explores how DPP-4 inhibitors might mitigate drug-resistant epilepsy through a hypothesized gut microbiota-SCFA-GLP-1…
New research explores how a common class of medications might protect the brain and improve gut health in patients with drug-resistant epile…
Transcutaneous auricular vagus nerve stimulation mechanisms and parameter optimization reviewed
Neurology Sys. Review
Transcutaneous auricular vagus nerve stimulation mechanisms and parameter optimization reviewed New research explores how ear nerve stimulation helps neurological conditions
This systematic review synthesizes neuroimaging, autonomic, and molecular pathways underlying transcutaneous auricular vagus nerve stimulati…
Scientists are mapping out how stimulating the vagus nerve through the ear could offer new ways to treat various neurological and systemic d…
Multidimensional biomarker panels suggest a complex pathological basis for post-stroke depression in the DRN-mPFC circuit
Neurology Sys. Review
Multidimensional biomarker panels suggest a complex pathological basis for post-stroke depression in the DRN-mPFC circuit New framework identifies biological markers for depression after a stroke
This narrative review synthesizes evidence regarding the biological drivers of post-stroke depression (PSD). It proposes a framework where P…
A new research framework identifies how different biological factors, like inflammation and chemicals in the brain, combine to cause depress…
Transitional care interventions reduce rehospitalization and improve quality of life in adult stroke survivors
Neurology Meta-analysis
Transitional care interventions reduce rehospitalization and improve quality of life in adult stroke survivors Transitional care helps stroke survivors stay out of the hospital
This systematic review and meta-analysis of 3,520 adult stroke survivors found that transitional care interventions reduced overall rehospit…
Specialized transitional care can cut hospital readmissions for stroke survivors by nearly half within three months of leaving the hospital.
Acupuncture-related therapies significantly reduce overall, physical, and mental fatigue in chronic fatigue syndrome patients
Neurology Meta-analysis
Acupuncture-related therapies significantly reduce overall, physical, and mental fatigue in chronic fatigue syndrome patients Acupuncture may help reduce physical and mental fatigue in CFS
This meta-analysis of 8 RCTs involving 715 patients found that acupuncture-related therapies were superior to control interventions for redu…
New data suggests acupuncture-related therapies can lower overall, physical, and mental fatigue for people living with chronic fatigue syndr…
Intravenous thrombolysis does not improve excellent functional recovery in patients with minor acute ischemic stroke
Neurology Meta-analysis
Intravenous thrombolysis does not improve excellent functional recovery in patients with minor acute ischemic stroke Thrombolytic drugs may not improve recovery for minor strokes
This meta-analysis of randomized controlled trials evaluated intravenous thrombolysis compared to nonthrombolytic standard of care for minor…
New data suggests that using clot-busting drugs might not provide extra benefits for patients with minor, non-disabling strokes.
cGAS-STING signaling pathway activation drives inflammation, fibrosis, and functional decline in various kidney diseases
Neurology Sys. Review
cGAS-STING signaling pathway activation drives inflammation, fibrosis, and functional decline in various kidney diseases Immune pathway linked to kidney disease progression
This systematic review explores the role of the cGAS-STING signaling pathway in renal pathologies. The authors conclude that this pathway is…
A newly mapped immune pathway may drive kidney damage, opening doors for future treatments.
FDA Approves Morphine Sulfate Oral Solution for Acute and Chronic Pain
Neurology FDA Approval
FDA Approves Morphine Sulfate Oral Solution for Acute and Chronic Pain FDA approves new morphine liquid for severe pain in adults and children.
The FDA approved Morphine Sulfate Oral Solution (2 mg/mL and 4 mg/mL) for acute and chronic pain in adults and pediatric patients 2 years an…
The FDA approved Morphine Sulfate Oral Solution for severe pain that requires an opioid and hasn't been helped by other treatments. It comes…
FDA Approves Xtampza ER (oxycodone) for Severe Persistent Pain
Neurology FDA Approval
FDA Approves Xtampza ER (oxycodone) for Severe Persistent Pain FDA approves new long acting painkiller Xtampza ER for severe pain
FDA approved Xtampza ER, an extended-release oxycodone, for severe persistent pain requiring an opioid when alternative options are inadequa…
The FDA approved Xtampza ER, a long acting oxycodone capsule, for severe pain that cannot be managed with other treatments. It is taken ever…